EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Athens Medical Centre's Enterprise Value is €311.5 Mil.
Athens Medical Centre's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-11.8 Mil. Therefore, Athens Medical Centre's EV-to-FCF for today is -26.33.
The historical rank and industry rank for Athens Medical Centre's EV-to-FCF or its related term are showing as below:
FRA:ACS'
s EV-to-FCF Range Over the Past 10 Years
Min: -37.81 Med: 16.69 Max: 80.44
Current: -25.81
During the past 13 years, the highest EV-to-FCF of Athens Medical Centre was 80.44. The lowest was -37.81. And the median was 16.69.
FRA:ACS's EV-to-FCF is ranked worse than 100% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 17.51
vs FRA:ACS: -25.81
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Athens Medical Centre (FRA:ACS) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Athens Medical Centre's PE Ratio (TTM) for today is calculated as:
Athens Medical Centre's share price for today is €1.705.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athens Medical Centre's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.054.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Athens Medical Centre's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athens Medical Centre EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Athens Medical Centre's EV-to-FCF falls into.
Athens Medical Centre's current Enterprise Value is €311.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athens Medical Centre's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-11.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Athens Medical Centre (FRA:ACS) has a EV-to-FCF of -26.33 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Athens Medical Centre and its competitors. According to the industry distribution chart, Athens Medical Centre ranks #999999 out of 407 companies in the Healthcare Providers & Services industry.
Is Athens Medical Centre's EV-to-FCF too high?
Athens Medical Centre's current EV-to-FCF is -26.33. Based on the distribution chart, Athens Medical Centre ranks #999999 out of 407 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Athens Medical Centre has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Athens Medical Centre ranks #999999 out of 407 companies for EV-to-FCF. This places Athens Medical Centre in the lower half of its industry. The industry median EV-to-FCF is 17.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.51, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Athens Medical Centre and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athens Medical Centre's current EV-to-FCF is -26.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Based on GuruFocus' analysis, Athens Medical Centre (FRA:ACS) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.02, compared to a current price of €1.71 — trading 15.6% below its estimated fair value. The current EV-to-FCF is -26.33. Athens Medical Centre's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current EV-to-FCF is -26.33 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?
Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued.
The current stock price of €1.71 is trading 15.6% below its estimated GF Value™ of €2.02.
GuruFocus considers Athens Medical Centre to be Modestly Undervalued.
Key valuation signals for FRA:ACS:
EV-to-FCF: -26.33
GF Value™: €2.02 vs. price of €1.71 (15.6% below fair value)
No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
69GF Score
Get the complete analysis for FRA:ACS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ACS has been successfully added to your 
